Market5 years ago
CRISPR Therapeutics (NASDAQ:CRSP), Chatham Lodging Trust (NYSE:CLDT) Set to Open Higher In Today’s Session
CRISPR Therapeutics (NASDAQ:CRSP) and development partner Vertex Pharmaceuticals (NASDAQ:VRTX) announce that the first beta thalassemia patient has been dosed with CTX001, a gene therapy based on...